Presentation THT 2025 Evidence That Challenges the Validity of KCCQ as a Measure of Quality of Life in Both Blinded and Unblinded Studies Presenter: Gregg Stone February 13, 2025
Presentation THT 2025 Evidence Supporting the Use of KCCQ as a Valid Measure of Quality of Life in Both Blinded and Unblinded Studies Presenter: David Cohen February 13, 2025
Presentation THT 2025 Down-Stream Challenges: Reimbursement and Guidelines Presenter: Philip Adamson February 13, 2025
Presentation THT 2025 Regulatory Considerations for the Use of AI for Treating Patients With Heart Failure: The Intersection of Drugs and Devices Presenter: Alex Cadotte February 13, 2025
Presentation THT 2025 Blurred Lines: TEAMing up to Illuminate the Heart Failure Referral Pathway Presenter: Jerry Estep February 12, 2025
Presentation THT 2025 Challenges in Designing Collaborative Clinical Therapeutic Trials in HT Presenter: Jeffrey Teuteberg February 12, 2025